Insight

Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma

winshipcancer.emory.edu

Dec 26, 2024, 14:23

Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma

Haematologica shared a post on X:

“Long non-coding RNA (lncRNA) have emerged as key players in the regulation of various biological processes.

A new study explores the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma.”

lncRNA

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Authors: Noemi Puccio, Gloria Manzotti, Elisabetta Mereu, Federica Torricelli, Domenica Ronchetti, Michela Cumerlato, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Valentina Traini, Veronica Manicardi, Valentina Fragliasso, Yvan Torrente, Nicola Amodio, Niccolò Bolli, Elisa Taiana, Alessia Ciarrocchi, Roberto Piva, Antonino Neri

lncRNA

Alessia Ciarrocchi Antonino Neri biological processes cancer Domenica Ronchetti Elisa Taiana Elisabetta Mereu Federica Torricelli Gloria Manzotti Haematologica Ilaria Craparotta Laura Di Rito lncRNA Marco Bolis Michela Cumerlato multiple myeloma Niccolò Bolli Nicola Amodio Noemi Puccio OncoDaily Oncology Roberto Piva Valentina Fragliasso Valentina Traini Veronica Manicardi Yvan Torrente

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage